Cartilage quality in rheumatoid arthritis: Comparison of T2* mapping, native T1 mapping, dGEMRIC, δr1 and value of pre-contrast imaging

Skeletal Radiology

Volumn 41, Issue 6, 2012, Pages 685-692

  Buchbender, Christian ^a   Scherer, Axel ^a   Kröpil, Patric ^a   Körbl, Birthe ^a,b   Quentin, Michael ^a   Dorothea, Ch Reichelt ^a   Lanzman, Rotem S ^a   Mathys, Christian ^a   Blondin, Dirk ^a   Bittersohl, Bernd ^b   Zilkens, Christoph ^b   Hofer, Matthias ^a   Wittsack, Hans Jörg ^a   Schneider, Matthias ^b   Antoch, Gerald ^a   Ostendorf, Benedikt ^b   Miese, Falk ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Department of Orthopedic Surgery   (Germany)

Author keywords

Cartilage; DGEMRIC; MRI; Rheumatoid arthritis; T1 mapping; T2* mapping

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARTILAGE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GADOLINIUM ENHANCED MAGNETIC RESONANCE IMAGING OF CARTILAGE; HUMAN; IMAGE ANALYSIS; MALE; METACARPOPHALANGEAL JOINT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; VOLUNTEER;

ADULT; AGED; ALGORITHMS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; METACARPOPHALANGEAL JOINT; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84863943520     PISSN: 03642348     EISSN: 14322161     Source Type: Journal    
DOI: 10.1007/s00256-011-1276-2     Document Type: Article

References (42)

1. Dodge GR, Pidoux I, Poole AR. The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study. Matrix. 1991;11(5):330-8.
2. Trattnig S, Mamisch TC, Welsch GH, Glaser C, Szomolanyi P, Gebetsroither S, et al. Quantitative T2 mapping of matrixassociated autologous chondrocyte transplantation at 3 Tesla: an in vivo cross-sectional study. Invest Radiol. 2007;42(6):442-8. (Pubitemid 46788745)
3. Welsch GH, Mamisch TC, Hughes T, Zilkens C, Quirbach S, Scheffler K, et al. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage. Invest Radiol. 2008;43 (9):619-26.
4. Mamisch TC, Hughes T, Mosher TJ, Mueller C, Trattnig S, Boesch C, et al. T2 star relaxation times for assessment of articular cartilage at 3 T: a feasibility study. Skeletal Radiol. 2011.
5. Marik W, Apprich S, Welsch GH, Mamisch TC, Trattnig S. Biochemical evaluation of articular cartilage in patients with osteochondrosis dissecans by means of quantitative T2- and T2*- mapping at 3T MRI: a feasibility study. Eur J Radiol. 2011.
6. Bittersohl B, Hosalkar HS, Hughes T, Kim YJ, Werlen S, Siebenrock KA, et al. Feasibility of T2* mapping for the evaluation of hip joint cartilage at 1.5T using a threedimensional (3D), gradient-echo (GRE) sequence: a prospective study. Magn Reson Med. 2009;62(4):896-901.
7. Bashir A, Gray ML, Burstein D. Gd-DTPA2? as a measure of cartilage degradation. Magn Reson Med. 1996;36(5):665-73.
8. Burstein D, Gray M, Mosher T, Dardzinski B. Measures of molecular composition and structure in osteoarthritis. Radiol Clin North Am. 2009;47(4):675-86.
9. Gillis A, Gray M, Burstein D. Relaxivity and diffusion of gadolinium agents in cartilage. Magn Reson Med. 2002;48 (6):1068-71. (Pubitemid 35398539)
10. Tiderius CJ, Olsson LE, Leander P, Ekberg O, Dahlberg L. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn Reson Med. 2003;49(3):488-92. (Pubitemid 36262816)
11. Watanabe A, Wada Y, Obata T, Ueda T, Tamura M, Ikehira H, et al. Delayed gadolinium-enhanced MR to determine glycosaminoglycan concentration in reparative cartilage after autologous chondrocyte implantation: preliminary results. Radiology. 2006;239(1):201-8.
12. Trattnig S, Marlovits S, Gebetsroither S, Szomolanyi P, Welsch GH, Salomonowitz E, et al. Three-dimensional delayed gadoliniumenhanced MRI of cartilage (dGEMRIC) for in vivo evaluation of reparative cartilage after matrix-associated autologous chondrocyte transplantation at 3.0T: preliminary results. J Magn Reson Imaging. 2007;26(4):974-82. (Pubitemid 47548159)
13. Tiderius CJ, Olsson LE, de Verdier H, Leander P, Ekberg O, Dahlberg L. Gd-DTPA2)-enhanced MRI of femoral knee cartilage: a dose-response study in healthy volunteers. Magn Reson Med. 2001;46(6):1067-71. (Pubitemid 33104293)
14. Li W, Du H, Scheidegger R, Wu Y, Prasad PV. Value of precontrast T(1) for dGEMRIC of native articular cartilage. J Magn Reson Imaging. 2009;29(2):494-7.
15. Bittersohl B, Hosalkar HS, Kim YJ, Werlen S, Siebenrock KA, Mamisch TC. Delayed gadolinium-enhanced magnetic resonance imaging (dGEMRIC) of hip joint cartilage in femoroacetabular impingement (FAI): are pre- and postcontrast imaging both necessary? Magn Reson Med. 2009;62(6):1362-7.
16. Miese FR, Ostendorf B, Wittsack HJ, Reichelt DC, Mamisch TC, Zilkens C, et al. Metacarpophalangeal joints in rheumatoid arthritis: delayed gadolinium-enhanced MR imaging of cartilage- a feasibility study. Radiology. 2010;257(2):441-7.
17. Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham Cr, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580-8.
18. Mamisch TC, Dudda M, Hughes T, Burstein D, Kim YJ. Comparison of delayed gadolinium enhanced MRI of cartilage (dGEMRIC) using inversion recovery and fast T1 mapping sequences. Magn Reson Med. 2008;60(4):768-73.
19. Miese F, Kropil P, Ostendorf B, Scherer A, Buchbender C, Quentin M. et al. Eur J Radiol: Motion correction improves image quality of dGEMRIC in finger joints. Eur J Radiol. 2011. doi:10.1016/j.ejrad.2011.01.006
20. Cimmino MA, Innocenti S, Livrone F, Magnaguagno F, Silvestri E, Garlaschi G. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease. Arthritis Rheum. 2003;48(5):1207-13. (Pubitemid 36554519)
21. Kirkhus E, Bjørnerud A, Thoen J, Johnston V, Dale K, Smith HJ. Contrast-enhanced dynamic magnetic resonance imaging of finger joints in osteoarthritis and rheumatoid arthritis: an analysis based on pharmacokinetic modeling. Acta Radiol. 2006;47(8):845-51. (Pubitemid 44521245)
22. Fouque-Aubert A, Chapurlat R, Miossec P, Delmas PD. A comparative review of the different techniques to assess hand bone damage in rheumatoid arthritis. Joint Bone Spine. 2010;77(3):212-7.
23. Ostendorf B, Mattes-György K, Reichelt DC, Blondin D, Wirrwar A, Lanzman R, et al. Early detection of bony alterations in rheumatoid and erosive arthritis of finger joints with highresolution single photon emission computed tomography, and differentiation between them. Skeletal Radiol. 2010;39(1):55-61.
24. Ostergaard M, Lorenzen I, Henriksen O. Dynamic gadoliniumenhanced MR imaging in active and inactive immunoinflammatory gonarthritis. Acta Radiol. 1994;35(3):275-81.
25. Vasanth L, Foo L, Potter H, Adler R, Finzel K, Pavlov H, et al. Using magnetic resonance angiography to measure abnormal synovial blood vessels in early inflammatory arthritis: a new imaging biomarker? J Rheumatol. 2010;37(6):1129-35.
26. Aletaha D, Funovits J, Smolen JS. Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction. Ann Rheum Dis. 2011;70(5):733-9.
27. Smolen JS, Aletaha D, Steiner G. Does damage cause inflammation? Revisiting the link between joint damage and inflammation. Ann Rheum Dis. 2009;68(2):159-62.
28. Hollander AP, Atkins RM, Eastwood DM, Dieppe PA, Elson CJ. Human cartilage is degraded by rheumatoid arthritis synovial fluid but not by recombinant cytokines in vitro. Clin Exp Immunol. 1991;83(1):52-7.
29. György B, Tóthfalusi L, Nagy G, Pásztói M, Géher P, Lörinc Z, et al. Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis. Arthritis Res Ther. 2008;10(5):R110.
30. Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis. 2005;64(2):196-201. (Pubitemid 40193611)
31. Turesson C, Bergström U, Jacobsson LT, Truedsson L, Berglund G, Saxne T. Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis. Ann Rheum Dis. 2011;70(3):520-2.
32. Gandy SJ, Brett AD, Dieppe PA, Keen MC, Maciewicz RA, Taylor CJ, et al. Measurement of cartilage volumes in rheumatoid arthritis using MRI. Br J Radiol. 2005;78(925):39-45. (Pubitemid 40277136)
33. McQueen F, Clarke A, McHaffie A, Reeves Q, Williams M, Robinson E, et al. Assessment of cartilage loss at the wrist in rheumatoid arthritis using a new MRI scoring system. Ann Rheum Dis. 2010;69(11):1971-5.
34. Tiderius CJ, Sandin J, Svensson J, Dahlberg LE, Jacobsson L. Knee cartilage quality assessed with dGEMRIC in rheumatoid arthritis patients before and after treatment with a TNF inhibitor. Acta Radiol. 2010;51(9):1034-7.
35. Girardi M, Kay J. Elston DM, Leboit PE, Abu-Alfa A, Cowper SE. Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol. 2011; in press.
36. Prince MR, Zhang H, Zou Z, Staron RB, Brill PW. Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol. 2011;196(2):W138-143.
37. Wang Y, Alkasab TK, Narin O, Nazarian RM, Kaewlai R, Kay J et al. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology. 2011;260(1):105-11.
38. Burstein D, Velyvis J, Scott KT, Stock KW, Kim YJ, Jaramillo D, et al. Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med. 2001;45(1):36-41. (Pubitemid 32044262)
39. Gillis A, Bashir A, McKeon B, Scheller A, Gray ML, Burstein D. Magnetic resonance imaging of relative glycosaminoglycan distribution in patients with autologous chondrocyte transplants. Invest Radiol. 2001;36(12):743-8. (Pubitemid 34024431)
40. Bashir A, Gray ML, Boutin RD, Burstein D. Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA) (2-)-enhanced MR imaging. Radiology. 1997;205(2):551-8. (Pubitemid 27467341)
41. Sanz R, Martí-Bonmatí L, Rodrigo JL, Moratal D. MR pharmacokinetic modeling of the patellar cartilage differentiates normal from pathological conditions. J Magn Reson Imaging. 2008;27 (1):171-7.
42. Christensen AF, Hørslev-Petersen K, Christgau S, Lindegaard HM, Lottenburger T, Junker K, et al. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides. J Rheumatol. 2010;37(6):1113-20.